About this event
Learn more about:
Cytonics' mission to rid the world of Osteoarthritis by leveraging the chondroprotective (cartilage and bone repairing) action of the Alpha-2-Macroglobulin (A2M) protein
Our APIC and FACT technologies to diagnose and treat osteoarthritis
Our recombinant drug development platform
Cytonics is a leader in the field of regenerative medicine and is positioned to disrupt the space with their innovative biologic therapies for musculoskeletal diseases.
Share this event